[ad_1]
Britain is expected to approve the coronavirus vaccine developed by BioNTech and Pfizer next week and deliveries will begin within hours of authorization, the Financial Times reported on Saturday.
The first vaccinations with the BioNTech and Pfizer vaccine could take place from December 7, the Financial Times said, citing anonymous sources.
READ MORE: Support for Mandatory Coronavirus Vaccine Continues to Diminish Even as Cases Rise: Ipsos
Earlier in the day, British Prime Minister Boris Johnson appointed Nadhim Zahawi, currently a young affairs minister, as the minister responsible for distributing COVID-19 vaccines.
On November 20, Britain said it formally asked its medical regulator, the Medicines and Health Products Regulatory Agency (MHRA), to assess the suitability of the Pfizer-BioNTech COVID-19 vaccine, the first step to make it available outside the United States. .
READ MORE: Here’s a look at what provinces and territories have said about vaccination plans
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.4 million people around the world and paralyzed the global economy.
On Friday, the government asked the regulator to evaluate AstraZeneca Plc’s COVID-19 vaccine for a possible launch.
It has secured 100 million doses of the vaccine developed by AstraZeneca and the University of Oxford and has planned a launch to begin before Christmas.
Canadian public health officials said last week that they plan to approve the vaccines with similar timelines to the US and European countries.
In a press conference Thursday, Dr Supriya Sharma, Health Canada’s chief medical consultant, said Pfizer’s vaccine could get approval from Canadian authorities in December.
View link »
.
[ad_2]
Source link
